Ten EMA initiatives will strengthen clinical research in Europe
The framework conditions for clinical research in Europe have proved challenging and difficult, the EMA says. With ten new initiatives, the European health authority wants to change how trials are designed, initiated and conducted. Industry association Lif welcomes the changes.
by ALBERT RØNNING-ANDERSSON, translated by daniel pedersen
Clinical trials are a necessity for the development of drugs, medical equipment, new treatments and the life science industry at large.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
